Secondly, in an AML mouse model, LSCs adhered to the vascular niche which protected LSCs from chemotherapy through E-selectin/E-selectin ligands and this effect was ameliorated by GMI-1271 (28). The gene discussed is SELE; the disease is acute myeloid leukemia.